Larimar Therapeutics Ownership | Who Owns Larimar Therapeutics?

Larimar Therapeutics Ownership Summary

Larimar Therapeutics is owned by 100.82% institutional investors, 1.45% insiders. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 39.65% of LRMR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.10% of its assets in Larimar Therapeutics shares.

LRMR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Larimar Therapeutics	100.82%	1.45%	-2.27%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Deerfield management company, l.p. (series c)	21.23M	39.65%	$153.93M
Ra capital management	6.05M	11.29%	$43.83M
Janus henderson group	4.38M	8.17%	$31.63M
Goldman sachs group	4.33M	8.09%	$31.41M
Blue owl capital lp	3.86M	7.21%	$27.98M
Blackrock	3.13M	5.85%	$22.72M
Vanguard group	2.54M	4.74%	$18.40M
Verition fund management	1.59M	2.98%	$11.56M
Adage capital partners gp	1.37M	2.56%	$9.94M
Driehaus capital management	1.31M	2.45%	$9.53M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Blue owl capital lp	3.86M	7.78%	$27.98M
Deerfield management company, l.p. (series c)	21.23M	2.56%	$153.93M
Dafna capital management	639.97K	1.11%	$4.64M
Ra capital management	6.05M	0.58%	$43.83M
Altium capital management lp	196.00K	0.58%	$1.42M
Mangrove partners	855.82K	0.48%	$6.20M
Ikarian capital	323.53K	0.41%	$2.35M
Sphera funds management	312.47K	0.31%	$2.27M
Atlas venture advisors	172.18K	0.27%	$1.25M
Artia global partners lp	90.49K	0.13%	$656.05K

Top Buyers

Holder	Shares	% Assets	Change
Goldman sachs group	4.33M	0.01%	915.20K
Blackrock	3.13M	0.00%	795.19K
Fmr	525.72K	0.00%	525.00K
Invesco	441.29K	0.00%	429.47K
Janus henderson group	4.38M	0.02%	356.42K

Top Sellers

Holder	Shares	% Assets	Change
Stempoint capital lp	-	-	-704.35K
Logos global management lp	-	-	-700.00K
Rtw investments, lp	-	-	-650.00K
Renaissance	278.34K	0.00%	-225.10K
Ghost tree capital	-	-	-210.60K

New Positions

Holder	Shares	% Assets	Change	Value
Sphera funds management	312.47K	0.31%	312.47K	$2.27M
Altium capital management lp	196.00K	0.58%	196.00K	$1.42M
Wellington management group llp	41.68K	0.00%	41.68K	$302.20K
Alliancebernstein	27.79K	0.00%	27.79K	$201.48K
Corebridge financial	22.63K	0.00%	22.63K	$164.08K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-5.00
Ica group wealth management	-75.00
Comerica bank	-415.00
Metropolitan life insurance co/ny	-1.41K
Group one trading	-8.64K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	127	15.45%	64,329,114	-1.50%	100	0.68%	65	4.84%	34	-
Jun 30, 2024	110	-1.79%	65,308,472	2.69%	121	0.58%	62	-17.33%	34	54.55%
Mar 31, 2024	112	51.35%	63,594,673	61.18%	144	1.79%	75	150.00%	22	-15.38%
Dec 31, 2023	74	10.45%	39,456,509	1.83%	89	1.15%	30	15.38%	26	8.33%
Sep 30, 2023	67	-	38,745,794	-0.72%	88	1.12%	26	-33.33%	24	84.62%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.34M	2.10%	-
iShares Russell 2000 ETF	1.10M	1.72%	-2.46K
Fidelity Advisor Biotechnology I	524.80K	0.82%	-
Vanguard Institutional Extnd Mkt Idx Tr	510.24K	0.80%	-
Fidelity Small Cap Index	431.07K	0.68%	-11.27K
Invesco Dorsey Wright SmallCap Momt ETF	422.53K	0.66%	-
Janus Henderson Hrzn Biotec E2 USD	411.08K	0.64%	-20.44K
Alger Small Cap Growth B	398.96K	0.63%	-
Heptagon Driehaus US Micro Cap Eq C$ Acc	392.25K	0.61%	3.19K
iShares Russell 2000 Growth ETF	372.43K	0.58%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 16, 2024	Hamilton Thomas Edward	-	Buy	$500.00K
Feb 16, 2024	Flynn James E	* Director by Deputization	Buy	$12.50M
Feb 16, 2024	Flynn James E	* Director by Deputization	Buy	$12.50M
Feb 16, 2024	Flynn James E	* Director by Deputization	Buy	$12.50M
Feb 14, 2024	THOMAS FRANK E	-	Buy	$22.00K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	5	-
2023 Q4	1	-
2023 Q3	-	-
2023 Q2	3	-

LRMR Ownership FAQ

Who Owns Larimar Therapeutics?

Larimar Therapeutics shareholders are primarily institutional investors at 100.82%, followed by 1.45% insiders and -2.27% retail investors. The average institutional ownership in Larimar Therapeutics's industry, Biotech Stocks , is 47.04%, which Larimar Therapeutics exceeds.

Who owns the most shares of Larimar Therapeutics?

Larimar Therapeutics’s largest shareholders are Deerfield management company, l.p. (series c) (21.23M shares, 39.65%), Ra capital management (6.05M shares, 11.29%), and Janus henderson group (4.38M shares, 8.17%). Together, they hold 59.11% of Larimar Therapeutics’s total shares outstanding.

Does Blackrock own Larimar Therapeutics?

Yes, BlackRock owns 5.85% of Larimar Therapeutics, totaling 3.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 795.19K shares, a 34.00% change.

Who is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.78% of its assets in 3.86M Larimar Therapeutics shares, valued at 27.98M$.

Who is the top mutual fund holder of Larimar Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Larimar Therapeutics shares, with 2.10% of its total shares outstanding invested in 1.34M Larimar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools